Grand Rounds Toolkit: PCSK9 Inhibitors

Grand Rounds Toolkit

Are you on faculty for an upcoming grand rounds? Consider these resources including slide with presenter notes and videos from SCAI's PCSK9-i course titled, "Improving Clinical Outcomes After PCI: Advances in Lipid Management and the Interventionalist’s Role."

Course Content

PowerPoint decks with lecture notes and recorded lectures:

Recent Updates in Primary and Secondary Prevention of CAD from Arnold Seto, MD, MPA, FSCAI
Emerging Role of PCSK9i for Primary (HeFH) and Secondary CAD Prevention: Physiology from Naomi Hamburg, MD
Clinical Outcomes With PCSK9 Inhibitors from Raghava S. Velagaleti, MD, MPH, FSCAI
Exploratory Cholesterol Reduction Methods in the Post-PCI Setting: Hype or Hope? from Subhash Banerjee, MD, FSCAI

Plus recorded panel discussion.

Course Faculty

L to R:
Raghava Velagelati, MD, MPH, FSCAI
Boston VA Healthcare System/Framingham Heart Study
Instructor in Medicine, Harvard Medical School

Naomi Hamburg, MD
Chief of the Vascular Biology Section
Joseph Vita Associate Professor of Cardiovascular Medicine
Boston University School of Medicine

Anold Seto, MD, MPA, FSCAI
Chief of Cardiology, Long Beach VA
Associate Clinical Professor, UC-Irvine

Subhash Banerjee, MD, FSCAI
Chief of Cardiology, Professor, Internal Medicine, VA North Texas Health Care System
Dallas Veterans Affairs Medical Center

Acknowledgement of Commercial Support


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered